Definition

A drug used to treat adults with certain types of cholangiocarcinoma (bile duct cancer), myeloid cancer, or lymphoid cancer that have certain changes in the structure of the FGFR1 gene or FGFR2 gene. It is also being studied in the treatment of other types of cancer. Pemigatinib blocks a protein called FGFR, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called Pemazyre.